Sreekanth Vemulapalli, MD
Enriched profileAssociate Professor of Medicine (Cardiology), with Tenure · Duke University Medical Center
Sreekanth Vemulapalli is Associate Professor of Medicine (Cardiology), with Tenure at Duke University Medical Center. OpenAlex indexes 393 publications with 16,947 citations (h-index 63); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Sreekanth Vemulapalli, MD, is Associate Professor of Medicine (Cardiology), with Tenure at Duke University Medical Center / Duke University School of Medicine. The public record shows 393 publications with 16,947 citations (h-index 63), centered on Atrial Fibrillation. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 6 companies, 4 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Circulation
- Top research focus: Atrial Fibrillation
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Sponsor: Duke University
- Heart Watch Study: a Pragmatic Randomized Controlled Trial
Sponsor: Yale University
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202534 payments$27,923openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20251 payment
- Edwards Lifesciences CorporationProgram year202413 payments$14,446openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.3%Statin19.3%Atorvastatin Calcium54%Rosuvastatin Calcium36%Pravastatin Sodium9%Part D≥77 patientsBeta blocker16.8%Metoprolol Succinate61%Carvedilol34%Metoprolol Tartrate5%Part D<11 patientsBlood & clotting
14.3%Factor Xa inhibitor8.4%Eliquis65%Xarelto35%Part D≥33 patientsP2Y12 inhibitor5.2%Clopidogrel100%Part D≥35 patientsMetabolism & gastrointestinal
6.4%SGLT2 inhibitor5.1%Jardiance70%Farxiga31%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- 2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
Duke University
FY2026$689,368U24HL165029 - Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders
Duke University
FY2026$609,736R01HL168940 - 2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
Duke University
FY2025$710,826U24HL165029
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.
Circulation. Cardiovascular imaging
Article2026 - Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights.
Circulation. Cardiovascular interventions
Article2026 - Prediction of Heart Failure Hospitalization or Death After TAVR.
Circulation. Cardiovascular interventions
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sreekanth-vemulapalli-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/sreek-vemulapalli-4aa7b0b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Sreekanth-Vemulapalli
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/globalindiandiaspora_hearthealth-southasianhealth-indiandiasporapodcast-activity-7219023054159388672-Rjc1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/DCRINews/status/1858253799401394276
- X / Twitter
x.com/DCRINews/status/1867630572463698119
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- Board Certified
Cardiovascular Disease, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Duke Echo Lab and Cardiac Diagnostic Unit
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →comphealth.duke.edu ↗ - Leader
Interventional Echocardiography group, Duke
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →comphealth.duke.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthpolicy.duke.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- Member
Duke AI Health / Duke Forge
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →forge.duke.edu ↗
Media & interviews
press, podcasts and appearances- Podcast guest
"Optimizing Long-Term Follow-Up with Sreekanth Vemulapalli and Ryan Ahern," Heart Valve Matters (TCTMD), Jan 31 2025
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com ↗ - Featured author/contributor
Radcliffe Cardiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗ - Video interview
Duke University Cardiology (YouTube)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.